Hims & Hers' 38.4% subscriber growth and $576.4 million online revenues highlight the power of its personalized subscription model.

Hims & Hers Health Inc. shares slid over 2.8% on Tuesday and continued declining after-hours trading after Eli Lilly ...

Eli Lilly (LLY) revealed a new stipulation regarding its business dealings with telehealth companies Ro and LifeMD (LFMD), ensuring that compounded versions of its GLP-1 weight-loss drugs are not ...

New collaboration delivers 50% off prescription sleep support for new customers who are struggling with insomnia and sleep ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: ...

LifeMD Inc Earnings Call Summary for Q1/2025 Q1 2025 revenue of $65.7M beat forecast, EPS positive at $0.01; stock rose 3.09% in aftermarket trading First positive GAAP net income reported ...

Following these results, LifeMD raised its full-year 2025 revenue guidance to a range of $268-$275 million, with an adjusted EBITDA forecast of $31-$33 million. Cantor Fitzgerald maintained its ...

Fintel reports that on December 4, 2024, Mizuho initiated coverage of LifeMD (NasdaqGM:LFMD) with a Neutral recommendation. Analyst Price Forecast Suggests 110.53% Upside As of December 3 ...

In April, drugmaker Novo Nordisk announced it would be collaborating with telehealth services such as Hims and LifeMD to start home shipments of its medication Wegovy for self-paying customers at ...